Selected Publications

Huang Y, Xing H, Osouli A, Guay-Woodford L, Chung EJ.: Investigation of Urinary Extracellular Vesicles as Novel and Safe Therapeutics for Autosomal Recessive Polycystic Kidney Disease (ARPKD). J Biomed Mater Res A. 114(2): e70047, Feb 2026 Notes: doi: 10.1002/jbma.70047.

Salcedo-Giraldo J, Wink KR, Dadzie N, Freiman A, Pyle T, Gordish-Dressman H, Moxey-Mims M, Dahl NK, Guay-Woodford LM, Gulati A; Inherited and Polycystic Kidney Disease (IPKD) Program at Children's National Hospital, Washington, DC. : Structured Application of Genetic Testing in a Pediatric Kidney Clinic. J Am Soc Nephrol. 37(1): 120-130, Jan 2026 Notes: doi:10.1681/ASN.0000000816.Epub 2025 July 29.

Viteri B, Morales-Tisnés T, Logan J, Zee J, Kaplan S, Back SJ, Hartung EA, Pradhan M, Guay-Woodford L, Furth SL, Amaral S, Tasian GE, Otero HJ.: US-derived Pediatric Kidney Length and Volume Percentiles by Age: A Big Data Approach. Radiol Artif Intell. 8(1): e250056, Jan 2026 Notes: doi: 10.1148/ryai.250056.

Gulati A, Caldovic L, Guay-Woodford LM.: Fibrocystin/polyductin (FPC): new functional insights into ARPKD pathogenesis revealed by informatics, comparative genomics, and model systems. Pediatr Nephrol. Jan 2026 Notes: doi: 10.1007/s00467-025-07129-x.Epub ahead of print.

Cadnapaphornchai MA, Dell KM, Gimpel C, Guay-Woodford LM, Gulati A, Hartung EA, Liebau MC, Mallett AJ, Marlais M, Mekahli D, Piccirilli A, Seeman T, Tindal K, Winyard PJD.: Polycystic Kidney Disease in Children: The Current Status and the Next Horizon. Am J Kidney Dis. 86(3): 383-392, Sep 2025 Notes: 2025 Mar 28:S0272-6386(25)00772-3. doi: 10.1053/j.ajkd.2025.01.022.

Soyfer B, Fedeles S, Ruyle W, Hoover E, Liebau MC, Hartung EA, Dell KM, Guay-Woodford LM, Perrone RD, Oberdhan D.: Qualitative Analysis and Comparison of Externally Led Patient-Focused Drug Development Concepts for Autosomal Recessive Polycystic Kidney Disease Against SONG Initiatives. Kidney Med. 7(11): 101110, Sep 2025 Notes: doi:10.1016/j.xkme.2025.101110.

Tu T, Ochoa A, Sood A, Drabik A, Chryst-Stangl M, Lane B, Wu G, Donovan F, Harper U, Chandrasekharappa S, Esezobor C, Solarin A, Hooper D, Sethna C, Amaral S, Kallash M, Rheault M, Verghese P, Dharnidharka V, Salmon E, Weng P, Srivastava T, Seifert ME, Pruette C, Selewski D, Gibson K, Hunley T, Abeyagunawardena A, Thalgahagoda S, Bagga A, Sinha A, Webb N, Greenbaum L, Gharavi A, Kiryluk K, Kretzler M, Guay-Woodford L, Sanna-Cherchi S, Bierzynska A, Koziell A, Welsh G, Saleem M, Rotimi C, Chambers E, Chan C; CureGN Consortium; PNRC Glomerular disease group; CIBMTR/NMDP Consortium; Jackson A, Adeyemo A, Gbadegesin R.: Polygenic Risk Scores and HLA Class II Variants are Biomarkers of Corticosteroid Response in Childhood Nephrotic Syndrome. medRxiv [Preprint]. Aug 7 2025 Notes: 2025.08.01.25332825.doi:10.1101/2025.08.01.25332825.

Cummins TD, Mariani LH, Wilkey DW, Jortani SA, Helmuth M, Rane MJ, Merchant ML, Kamigaki Y, Theesfeld C, McCown PJ, Ju W, Dougherty JA, McRitchieS, Pathmasiri W, Kretzler M, Sumner SJ, Smoyer WE, Klein JB; Cure Glomerulonephropathy (CureGN) Consortium.: Defining subgroups of pediatric nephrotic patients with urine proteomics. Sci Rep. 15(1): 25064, Jul 2025.

Gimpel C, Fieuws S, Hofstetter J, Pitcher D, Vanmeerbeek L, Haeberle S, Dachy A, Massella L, Seeman T, Ranchin B, Allard L, Bacchetta J, Bayrakci US, Becherucci F, Perez-Beltran V, Besouw M, Bialkevich H, Boyer O, Canpolat N, Chauveau D, Çiçek N, Conlon PJ, Devuyst O, Dossier C, Fila M, Flögelová H, Godron-Dubrasquet A, Gokce I, Nguyen-Tang EG, González-Rodríguez JD, Guffens A, Grandaliano G, Heidet L, Jankauskiene A, Levart TK, Knebelmann B, König JC, La Scola C, Leone VF, Leroy V, Litwin M, Lucchetti L, Lungu AC, Marzuillo P, Mastrangelo A, Miklaszewska M, Montini G, Nobili F, Obrycki L, Papizh S, Paripović A, Paripović D, Peruzzi L, Raes A, Saygili S, Spasojević B, Simon T, Szczepańska M, Trepiccione F, Varda NM, Westland R, Yüksel S, Zaluska-Lesniewska I, Tenebaum J, Mustafa R, Mallett AJ, Guay-Woodford LM, Gale DP, Böckenhauer D, Liebau MC, Schaefer F, Mekahli D; RaDaR ADPKD Rare Disease Group; ERKReg Collaborators; ADPedKD Collaborators.: Insights from ADPedKD, ERKReg and RaDaR registries provide a multi-national perspective on the presentation ofchildhood autosomal dominant polycystic kidney disease in high- and middle-income countries. Kidney Int. 108(1): 105-118, Jul 2025 Notes: Epub 2025 Mar 21.

Watson D, Mentch F, Billings J, Ostberg K, March ME, Kalish JM, Li D, Cannon I, Guay-Woodford LM, Hartung E, Strong A.: Elucidating the Molecular Landscape of Cystic Kidney Disease: Old Friends, New Friends and Some Surprises. Am J Med Genet A. 197(6): e64011, Jun 2025 Notes: Epub 2025 Jan 30.